[Beta 3-adrenergic receptor].
Furutani
Y
Y
Discovery Research Laboratories, Dainippon Pharmaceutical Co., Ltd., Suita, Japan. yasuji-furutani@dainippon-pharm.co.jp
Karasawa
T
T
D000273:Adipose Tissue / Q000378:metabolism; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000818:Animals; D003920:Diabetes Mellitus / Q000188:drug therapy / Q000209:etiology; D015195:Drug Design; D004734:Energy Metabolism; D006801:Humans; D007333:Insulin Resistance; D009765:Obesity / Q000188:drug therapy / Q000209:etiology; D011943:Receptors, Adrenergic, beta / Q000502:physiology; D022702:Receptors, Adrenergic, beta-3; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism / Q000502:physiology
D000318:Adrenergic beta-Agonists; D011943:Receptors, Adrenergic, beta; D022702:Receptors, Adrenergic, beta-3; D014409:Tumor Necrosis Factor-alpha